Even though changes in the PI3K gene can cause a variety of cancers, when referring to BC, PI3K mutation or amplification and other aberrations in the PI3K signaling pathway can often be observed in hormone receptor-positive (HR+) BC. Here, NR4A1 is linked to breast cancer.